In the ®rst half of the twentieth century sulphaemoglobinaemia was associated mainly with use of aniline derivatives, sulphonamides and nitrates 1 . Formed by the production of a ferrohaemoglobin-peroxide complex which is sulphated in the presence of hydrogen sulphide, sulphaemoglobin persists for the life of the red cell. The terms microbic cyanosis 2 and enterogenous cyanosis 3 re¯ected the early belief that enteric organisms were involved in the pathogenesis.
CASE HISTORY
A woman aged 61 was investigated in 1985 for breathlessness and an iron de®ciency anaemia. She had a history of farmer's lung. Upper gastrointestinal endoscopy showed oesophagitis; nothing abnormal was seen on colonoscopy. Breathlessness persisted despite correction of anaemia. In 1991, peripheral cyanosis was noted but was attributed to restrictive lung disease. In 1992 central cyanosis was seen; methaemoglobin was not detected and the combination of PO 2 9.4 kPa with oxygen saturation 77% on room air suggested a reduced oxygen binding af®nity of haemoglobin. By February 1994 the cyanosis had increased and sulphaemoglobin (SHb) was found by spectrophotometry to be 7.0% (normal 0±0.7%) of a total haemoglobin of 14.4g/dL. The patient was taking regular paracetamol, dihydrocodeine, iron and omeprazole. Analysis of her drinking water showed no excess nitrate.
All drugs were stopped, but by May 1994 SHb had risen to 10.6%. From July 1994 she was treated with 2 g oral neomycin daily for six weeks, after we had found a case report of this treatment. By August SHb had fallen to 5.0% and after a further four months it was 0.6% and symptoms had improved. In the subsequent year SHb fell to 50.1% without further treatment but by February 1997 it had risen again to 5.9%. After another six-week course of neomycin SHb was 1.4%. Over the next year SHb rose gradually to 3.9% and, despite eight weeks of neomycin, to 5.9%. After a further two months of treatment no SHb was detectable.
Stool samples were cultured on three occasionsÐApril 1997, shortly after neomycin treatment, when SHb was near normal; in August 1998 with SHb 4.1% on neomycin; and in December 1998 off neomycin with no detectable SHb. Dilutions of faecal samples, down to 1 in 10 710 , were cultured on selective and non-selective media, including anaerobic neomycin blood agar, for 48 hours. Isolates were identi®ed to species level. The ®rst specimen yielded an almost pure growth of antibiotic sensitive Escherichia coli. This organism did not have any unusual characteristics and did not produce hydrogen sulphide. The two later specimens contained mainly anaerobic faecal¯ora; no hydrogen-sulphide-producing organisms were found.
COMMENT
The use of neomycin in this case was prompted by the report of Rossi et al. 4 , on a patient with combined methaemoglobinaemia and sulphaemoglobinaemia treated on one occasion with neomycin 4 . There has since been a further report, of a patient from Denmark with combined methaemoglobinaemia responding to treatment with neomycin and bacitracin 5 . In our patient with recurrent sulphaemoglobinaemia the effect of the ®rst two courses of neomycin seems clear; on the third occasion, delayed disappearance of SHb may have been attributable to normal clearance mechanisms. We wondered whether our patient's chronic use of paracetamol, with omeprazole acting as a sulphur donor, might have been the cause, but this explanation was ruled out by persistence of sulphaemoglobinaemia when the drugs were stopped. The patient differed from the two others reported, in not having a raised methaemoglobin. The response to poorly absorbed antibiotics suggests a bacterial mechanism in this type of cyanosis but we have been unable to identify the organism.
